Comparison between two separate injections and single injection for double dose Gadolinium enhanced MRI of metastatic brain tumors.

Comparison between two separate injections and single injection for double dose Gadolinium enhanced MRI of metastatic brain tumors. - Two separate injections and single injection for double dose Gadolinium enhanced MRI of metastatic brain tumors.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000026243

Enrollment

Registered

2017-02-22

Start date

2010-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

metastatic brain tumor

Interventions

two separate injections group single injection group.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Cases in which metastatic brain tumor is suspected

Exclusion criteria

Exclusion criteria: Cases with serious side effect. Cases with hypersensitivity with Gadoteridol. Cases with serious renal dysfunction.

Design outcomes

Primary

Measure	Time frame
Number of visualized lesions	—

Secondary

Measure	Time frame
Visualization of the edge or internal structure of the lesions	—

Countries

Japan

Contacts

Public ContactToshiaki Taoka

Nara Medical University Hospital Department of Radiology

ttaoka@naramed-u.ac.jp0744-22-3051

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026